Delivery Order SPE2DB25D3005-SPE2DB25FQDTT

Award Date 3/31/25
Potential Completion Date 4/1/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,707.20 firm fixed-price delivery order is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has an ultimate completion date of January 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,039.74, is a Firm Fixed Price Delivery Order for the supply of "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML" medical products. The contract has an ultimate completion date of April 10, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $7,460.44, is for the delivery of ZEPBOUND 15 MG/0.5 ML PEN 0.5ML medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of December 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,370.19, is a Firm Fixed Price Delivery Order for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical products. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,525.16, is a Firm Fixed Price Delivery Order for the supply of the medical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML". The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,525.16, for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.S ML medical products. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,978.53, is a delivery order that provides ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical supplies on a firm fixed-price basis. The contract has an ultimate completion date of December 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,498.02, is a delivery order for the supply of medical products, including the ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of February 19, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,812.90 Firm Fixed Price Delivery Order contract is for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML medical products. The contract has an ultimate completion date of February 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $3,207.76 firm fixed-price Delivery Order contract is for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a medical product, to support military healthcare programs. The contract has an ultimate completion date of January 22, 2025 and was awarded on January 21, 2025. AmerisourceBergen holds a significant...
  • SPE2DB25D3005
    Indefinite Delivery Contract
  • SPE2DB25D3005-SPE2DB25FQDTT
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,920.28, is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical supplies. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 6/30/25, 10:54 AM